Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: Systematic review and meta-analysis

BMJ (Online)

Volumn 354, Issue , 2016, Pages

  Siemieniuk, Reed A ^a,b   Agoritsas, Thomas ^a,c   Manja, Veena ^a,d,e   Devji, Tahira ^a   Chang, Yaping ^a   Bala, Malgorzata M ^f   Thabane, Lehana ^a   Guyatt, Gordon H ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY AT BUFFALO   (United States)

^e VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^f JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; CEREBROVASCULAR ACCIDENT; DISEASE SEVERITY; HEART FAILURE; HEART INFARCTION; HUMAN; META ANALYSIS; MORTALITY; PACEMAKER IMPLANTATION; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETREATMENT; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84990911142     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i5130     Document Type: Article

References (40)

1. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J 1987; 8: 471-83
2. HCUPnet. Healthcare Cost and Utilization Project Rockville, MD Agency for Healthcare Research and Quality. [Available from: http://hcupnet.ahrq.gov/.
3. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a populationbased study. Lancet 2006; 368: 1005-11. doi: 10.1016/S0140-6736(06)69208-8
4. Holmes DR Jr, Nishimura RA, Grover FL, et al. STS/ACC TVT Registry. Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. J Am Coll Cardiol 2015; 66: 2813-23. doi: 10.1016/j. jacc.2015.10.021
5. Vahanian A, Alfieri O, Andreotti F, et al. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-96. doi: 10.1093/eurheartj/ehs109
6. Nishimura RA, Otto CM, Bonow RO, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2438-88. doi: 10.1016/j.jacc.2014.02.537
7. Petronio AS, Capranzano P, Barbato E, et al. Current status of transcatheter valve therapy in Europe: results from an EAPCI survey. EuroIntervention 2016; 12: 890-5. doi: 10.4244/EIJY16M06-01
8. Leon MB, Smith CR, Mack MJ, et al. PARTNER 2 Investigators. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016; 374: 1609-20. doi: 10.1056/NEJMoa1514616
9. Gargiulo G, Sannino A, Capodanno D, et al. Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Ann Intern Med 2016; 165: 334-44. doi: 10.7326/M16-0060
10. Siontis GC, Praz F, Pilgrim T, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-Analysis of randomized trials. Eur Heart J 2016; ehw225. doi: 10.1093/eurheartj/ehw225
11. Vandvik PO, Otto CM, Siemieniuk RA, et al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ 2016; 354: i5085
12. Siemieniuk RA, Agoritsas T, Macdonald H, Guyatt GH, Brandt L, Vandvik PO. Introduction to BMJ Rapid Recommendations. BMJ 2016; 354: i5191
13. Foroutan F, Guyatt GH, O'Brien K, et al. Prognosis after surgical replacement with a biprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. BMJ 2016; 354: i5065
14. Lytvyn L, Guyett GH, Manja V, et al. Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: a systematic review. BMJ Open 2016; 6: e0147327
15. Siemieniuk RA, Agoritsas T, Manja V, et al. PROTOCOL: Transcatheter versus surgical aortic valve replacement in low and intermediate risk patients with severe aortic stenosis: a systematic review and meta-Analysis. PROSPERO, 2016 http://www.crd.york.ac.uk/PROSPERO/display-record.asp?ID=CRD42016042879
16. Cao C, Ang SC, Indraratna P, et al. Systematic review and metaanalysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg 2013; 2: 10-23
17. Health Information Research Unit. Search Filters for MEDLINE in Ovid Syntax and the PubMed translation 2016 http://hiru.mcmaster.ca/hiru/HIRU-Hedges-MEDLINE-Strategies.aspx
18. Health Information Research Unit. Search Strategies for EMBASE in Ovid Syntax 2016 http://hiru.mcmaster.ca/hiru/HIRU-Hedges-EMBASE-Strategies.aspx
19. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 2012; 33: 2403-18. doi: 10.1093/eurheartj/ehs255
20. Busse JWG. G. Modification of Cochrane tool to assess risk of bias in randomized trials 2013 https://distillercer.com/wp-content/uploads/2014/02/Tool-To-Assess-Risk-of-Bias-in-Randomized-Controlled-Trials.docx
21. Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6. doi: 10.1136/bmj.39489.470347.AD.
22. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ. GRADE Working Group. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008; 336: 995-8. doi: 10.1136/bmj.39490.551019.BE.
23. Akl EA, Johnston BC, Alonso-Coello P, et al. Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers. PLoS One 2013; 8: e57132. doi: 10.1371/journal.pone.0057132
24. Siemieniuk R, Vandvik P, Alonso-Coello P, et al. Hartung-Knapp-Sidik-Jonkman confidence intervals can be bizarrely narrow when heterogeneity is very low. Cochrane Colloquium. Seoul, Korea, 2016
25. Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 2012; 12: 9. doi: 10.1186/1471-2288-12-9
26. Adams DH, Popma JJ, Reardon MJ, et al. U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a selfexpanding prosthesis. N Engl J Med 2014; 370: 1790-8. doi: 10.1056/NEJMoa1400590
27. Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention 2012; 8: 383-9. doi: 10.4244/EIJV8I3A58
28. Thyregod HG, Steinbrüchel DA, Ihlemann N, et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol 2015; 65: 2184-94. doi: 10.1016/j.jacc.2015.03.014
29. Arnold SV, Reynolds MR, Wang K, et al. CoreValve US Pivotal Trial Investigators. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial. JACC Cardiovasc Interv 2015; 8: 1207-17. doi: 10.1016/j.jcin.2015.04.018
30. Chatterjee S, Kumbhani DJ, Sardar P, et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: an updated review of literature. Curr Cardiol Rep 2014; 16: 473. doi: 10.1007/s11886-014-0473-8
31. Deeb GM, Reardon MJ, Chetcuti S, et al. CoreValve US Clinical Investigators. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2016; 67: 2565-74. doi: 10.1016/j.jacc.2016.03.506
32. Reardon MJ, Adams DH, Kleiman NS, et al. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2015; 66: 113-21. doi: 10.1016/j. jacc.2015.05.017
33. Søndergaard L, Steinbrüchel DA, Ihlemann N, et al. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial. Circ Cardiovasc Interv 2016; 9: e003665. doi: 10.1161/CIRCINTERVENTIONS.115.003665
34. Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable?. Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010; 340: c117. doi: 10.1136/bmj.c117
35. Meyerson J, Thelin S, Gordh T, Karlsten R. The incidence of chronic post-sternotomy pain after cardiac surgery-A prospective study. Acta Anaesthesiol Scand 2001; 45: 940-4. doi: 10.1034/j.1399-6576.2001.450804.x.
36. Kocaaslan C, Ketenci B, Yilmaz M, et al. Comparison of Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement to Improve Quality of Life in Patients >70 Years of Age with Severe Aortic Stenosis. Braz J Cardiovasc Surg 2016; 31: 1-6
37. Abdel-Wahab M, Neumann FJ, Mehilli J, et al. CHOICE Investigators. 1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial. J Am Coll Cardiol 2015; 66: 791-800. doi: 10.1016/j.jacc.2015.06.026
38. Kodali S, Thourani VH, White J, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J 2016; 37: 2252-62. doi: 10.1093/eurheartj/ehw112
39. Manoharan G, Walton AS, Brecker SJ, et al. Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System. JACC Cardiovasc Interv 2015; 8: 1359-67. doi: 10.1016/j.jcin.2015.05.015
40. Borger MA, Moustafine V, Conradi L, et al. A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. Ann Thorac Surg 2015; 99: 17-25. doi: 10.1016/j.athoracsur.2014.09.022